Characterization of in vivo-acquired resistance to macrolides of Mycoplasma gallisepticum strains isolated from poultry
Open Access
- 2 August 2011
- journal article
- Published by Springer Science and Business Media LLC in Veterinary Research
- Vol. 42 (1), 90
- https://doi.org/10.1186/1297-9716-42-90
Abstract
The macrolide class of antibiotics, including tylosin and tilmicosin, is widely used in the veterinary field for prophylaxis and treatment of mycoplasmosis. In vitro susceptibility testing of 50 strains of M. gallisepticum isolated in Israel during the period 1997-2010 revealed that acquired resistance to tylosin as well as to tilmicosin was present in 50% of them. Moreover, 72% (13/18) of the strains isolated from clinical samples since 2006 showed acquired resistance to enrofloxacin, tylosin and tilmicosin. Molecular typing of the field isolates, performed by gene-target sequencing (GTS), detected 13 molecular types (I-XIII). Type II was the predominant type prior to 2006 whereas type X, first detected in 2008, is currently prevalent. All ten type X strains were resistant to both fluoroquinolones and macrolides, suggesting selective pressure leading to clonal dissemination of resistance. However, this was not a unique event since resistant strains with other GTS molecular types were also found. Concurrently, the molecular basis for macrolide resistance in M. gallisepticum was identified. Our results revealed a clear-cut correlation between single point mutations A2058G or A2059G in domain V of the gene encoding 23S rRNA (rrnA, MGA_01) and acquired macrolide resistance in M. gallisepticum. Indeed, all isolates with MIC ≥ 0.63 μg/mL to tylosin and with MIC ≥ 1.25 μg/mL to tilmicosin possess one of these mutations, suggesting an essential role in decreased susceptibility of M. gallisepticum to 16-membered macrolides.Keywords
This publication has 30 references indexed in Scilit:
- MEGA5: Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary Distance, and Maximum Parsimony MethodsMolecular Biology and Evolution, 2011
- Mutations in 23S rRNA gene associated with decreased susceptibility to tiamulin and valnemulin in Mycoplasma gallisepticumFEMS Microbiology Letters, 2010
- Comparative Pharmacokinetics/Pharmacodynamic Modeling on Three Brands of 10% Enrofloxacin Oral Formulations in Broiler ChickensInternational Journal of Poultry Science, 2010
- First Report of Macrolide-Resistant Strains and Description of a Novel Nucleotide Sequence Variation in the P1 Adhesin Gene in Mycoplasma pneumoniae Clinical Strains Isolated in France over 12 YearsJournal of Clinical Microbiology, 2007
- Setting and Revising Antibacterial Susceptibility BreakpointsClinical Microbiology Reviews, 2007
- Characterization of In Vivo Acquired Resistance of Mycoplasma hyopneumoniae to Macrolides and LincosamidesMicrobial Drug Resistance, 2005
- Emergence of Macrolide-Resistant Mycoplasma pneumoniae with a 23S rRNA Gene MutationAntimicrobial Agents and Chemotherapy, 2005
- Evaluation and Comparison of Various PCR Methods for Detection of Mycoplasma gallisepticum Infection in ChickensAvian Diseases, 2005
- Characterization and Molecular Analysis of Macrolide-Resistant Mycoplasma pneumoniae Clinical Isolates Obtained in JapanAntimicrobial Agents and Chemotherapy, 2004
- In vitro evaluation of various antimicrobials against Mycoplasma gallisepticum and Mycoplasma synoviae by the micro‐broth method, and comparison with a commercially‐prepared test systemAvian Pathology, 1994